Basic HTML Version
- 508 -
Low recurrent stenosis after coronary silicon carbide coated cobalt chromium stent
stenting and abciximab for complex coronary artery lesions: clinical results
of a single-center study.
Italian Heart Journal
(2004) 5 (9), 663-666.
28. Hamm CW, Hugenholtz PG; TRUST Investigators. Silicon carbide-
coated stents in patients with acute coronary syndrome.
Catheter
Cardiovasc Interv
2003 Nov;60(3):375-81.
29. Ryan TJ, Faxon DP, Gunnar RP, ACC/AHA Task Force: Guidelines
for percutanous transluminal coronary angioplasty.
J Am Coll Cardiol
12:529-545, 1988.
30 Bittl JA, Ryan TJ, Jeeny JF, Tcheng JE, Ellis SG, lsner JM, Sanborn TA.
Coronary artery Perforation during excimer laser angioplasty.
J Am Coll
Cardiol
1993:21:1158-1165.
31 Huber MS, Mooney JF, Madison J, Mooney MR. Use of a morpho-
logic classification to predict clinical outcome after dissection from coro-
nary angioplasty.
Am J Cardiol
1991; 68:467-471.
32. The TIMI III A Investigators. Early effects oftissue-type plasminogen
activator added to conventional therapy on the culprit coronary lesion in
patients presenting with ischernic cardiac pain at rest.
Circulation
1993;87:38-52.
33. Haase J, Escaned J, van Swijndregt EM, Ozaki Y, Gronenschild E,
Slager CJ, Serruys PW. Experimental validation of geometric and densito-
metric coronary measurements of the new generation Cardiovascular
Angiography Analysis System (CAAS II). Catherization and Cardiovascular
Diagnosis 27:16-27, 1993.
34 Gronenschild E, Janssen J, Tijdens F. CAAS II: A Second Generation
System for OFF-line and On-line Quantitative Coronary Angiography.
Catherization and Cardiovascular Diagnosis
33:61-75, 1994.
35. Welt FG, Rogers C. Inflammation and restenosis in the stent era.
Arteriocler Thromb Vasc Biol
2002 Nov 1;22(11):1769-76.
36 Kornowski R, Minz GS, Kent KM, Pichard AD, Satler LF, Bucher TA,
Hong MK, Popma JJ, Leon MB. Increased restenosis in diabetes mellitus
after coronary interventions is due to exaggerated intimal hyperplasia: a
serial intravascular ultrasound study.
Circulation
95:1366-1369, 1997.
37 Eschwege E, Richard JL, Thibult N, Ducimetiere P, Warnet JM,
Dlaude JR, Rosselin GE: The Paris Prospective Study, ten years later.
Horm Metab Res
15 (Suppl.Series) 41-46, 1985.
38. Sierevogel MJ, Velema E, van der Meer FJ, Nijhuis MO, Smeets M,
de Kleijn DP, Borst C, Pasterkamp G. Matrix metalloproteinase inhibition
reduces adventitial thickening and collagen accumulation following bal-
loon dilation.
Cardiovasc Res.
2002 Sep;55(4):864-9.
39. Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Münzel T,
Popma JJ, Fitzgerald PJ, Bonan R, Kuntz RE; ENDEAVOR II Investigators.
Randomized, double-blind, multicenter study of the Endeavor zotarolimus-
eluting phosphorylcholine-encapsulated stent for treatment of native coro-
nary artery lesions: clinical and angiographic results of the ENDEAVOR II
trial.
Circulation.
2006 Aug 22;114(8):798-806. Epub 2006 Aug 14.
15. Clowes AW, Clowes MM, Fingerle J, Reidy MA. Regulation
of smooth muscle cell growth in injured artery (1989)
Journal
of Cardiovascular Pharmacology,
14 (Suppl. 6), pp. S12-S15.
16. Kipshidze N, Dangas G, Tsapenko M, Moses J, Leon MB, Kutryk M,
Serruys P. Role of the endothelium in modulating neointimal formation:
Vasculoprotective approaches to attenuate restenosis after percutaneous
coronary interventions.
Journal of the American College of Cardiology
(2004);44(4), 733-739.
17. Windecker S, Simon R, Lins M, Klauss V, Eberli FR, Roffi M,
Pedrazzini G, Moccetti T, Wenaweser P, Togni M, Tüller D, Zbinden R,
Seiler C, Mehilli J, Kastrati A, Meier B, Hess OM. Randomized comparison
of a titanium-nitride-oxide-coated stent with a stainless steel stent for coro-
nary revascularization: the TiNOX trial.
Circulation.
2005 May 24;111(20):
2617-22. Epub 2005 May 9.
18. Lin C-E, Janero DR, Garvey DS. Nitric oxide-based molecular strate-
gies for restenosis therapyExpert Opinion on Therapeutic Patents
(2005)15 (5), pp. 483-495.
19. Hou D, Narciso H, Kamdar K, Zhang P, Barclay B, March KL.
Stent-based nitric oxide delivery reducing neointimal proliferation in
a porcine carotid overstretch injury model.
CardioVascular and
Interventional Radiology
(2005)28 (1), 60-65.
20. Harder C, Rzany A, Schaldach M. Coating of Vascular Stents with
Antithrombogenic Amorphous Silicon Carbide.
Prog Biomed Res.
(1999);
4: 71-77.
21. Van Oeveren W. Reduced deposition of blood formed elements and
fibrin onto amorphous silicon carbide coated stainless steel.
Prog Biomed
Res.
(1999); 4: 78-83.
22. Rzany A, Schaldach M, Hahn C, Harder C. Fibrin formation on sil-
icon carbide - A molecular level study with Scanning Force Microscopy.
Prog Biomed Res.
1999; 4: 84-89.
23. Rzany A, Schaldach M. Smart Material Silicon Carbide: Reduced
Activation of Cells and Proteins on a-SiC:H-coated Stainless Steel.
Prog
Biomed Res
(2001) 4: 182-194.
24. Monnink S, Boven A, Peels HO, Tigchelaar I, de Kam PJ, Crijns HJ,
van Oeveren W. Silicon-carbide coronary stents have low platelet and
leukocyte adhesion during platelet activation.
Journal of Investigative
Medicine.
1999; 47: 304-310.
25. Heublein B, Pethig K, Elsayed AM. Silicon carbide coating - A semi-
conducting hybrid design of coronary stents. A feasibility study.
J Invas
Cardiol.
1998; 10: 255-262.
26. Koolen J, Hanekamp C, Bonnier H. A highly flexible slotted tube
stent design coated with a-SiC:H. First clinical experiences.
Prog Biomed
Res.
1998; 3: 40-44.
27. van der Vleuten, P.A., Wijpkema, J.S., van den Heuvel, A.F., Bosma,
C.A., Jessurun, G.A., Tio, R.A. Treatment synergy of silicon carbide-coated